https://www.selleckchem.com/pr....oducts/ldn-212854.ht
Gout treatment is not optimized globally, often due to therapeutic inertia by physicians or poor adherence to urate-lowering medications by patients. A patient decision aid (PDA) to facilitate shared decision making (SDM) in gout treatment may overcome these physician-patient barriers. The study explored the views of physicians and patients on a novel locally designed gout treatment PDA prototype. Qualitative descriptive design was used to gather data from in-depth-interviews (IDI) and focus group discussions (FGD). Data analysis was
Like
Comment
Share
